跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“Borrelia burgdorfii”
全部
47
临床试验
26
药物
2
机构
0
资讯
19
去年
Valneva-Pfizer Lyme Disease Vaccine Shows Promise with Strong Booster Response in Phase 2 Trial
3个月前
Borrelia mayonii Lyme Disease Detected in New York for the First Time, Raising Concerns About Geographic Spread
5个月前
Pfizer and Valneva's Lyme Disease Vaccine Shows 73% Efficacy in Phase 3 Trial
8个月前
Tonix Pharmaceuticals Advances TNX-4800 Monoclonal Antibody for Lyme Disease Prevention with FDA Meeting Planned for 2026
去年
Lyme Disease Pipeline Shows Promise with 7+ Therapies in Development as Valneva-Pfizer Vaccine Advances
去年
Tonix Pharmaceuticals Licenses Long-Acting Monoclonal Antibody TNX-4800 for Seasonal Lyme Disease Prevention
上个月
Ticks Carrying Lyme Disease Reach Northeast-Level Infection Rates in Western North Carolina Residential Yards
去年
Drug Repurposing Breakthroughs: Established Medications Show Promise in Cancer, Lyme Disease, and Neurological Disorders
2个月前
Anti-Lipid Antibodies Show Promise for Earlier Lyme Disease Detection
4个月前
Dapsone Combination Therapy Reverses Alzheimer's Biomarkers in Chronic Lyme Disease Patient
第 1 页,共 2 页
上一页
下一页